Bacterial News and Research

RSS

Implicit wins $16.3 million U.S. government contract to develop its clinical stage drug oglufanide disodium

Implicit Bioscience has announced that it has been awarded a US$16.34 million (AU$18.2million) contract payable over 37 months from the United States Defense Threat Reduction Agency (DTRA) to develop its clinical stage drug oglufanide disodium as a broad spectrum therapeutic for the treatment of a number of intracellularbacterial diseases.

22 Oct 2007

Bacteria use plant defence for genetic modification

Bacteria that cause tumours in plants modify plant genomes by skilfully exploiting the plants' first line of defence.

22 Oct 2007

Massive reanalysis of genome data solves case of the lethal genes

It is better to be looked over than overlooked, Mae West supposedly said. These are words of wisdom for genome data-miners of today.

19 Oct 2007

FDA expands approved age range for Menactra, bacterial meningitis vaccine

The U.S. Food and Drug Administration has expanded the approved age range for Menactra, a bacterial meningitis vaccine, to include children ages 2 to 10 years.

19 Oct 2007

FDA approves doripenem injection to treat complicated urinary tract and intra-abdominal infections

The U.S. Food and Drug Administration has approved doripenem injection, 500 mg intravenous infusion, for the treatment of complicated urinary tract and intra-abdominal infections.

19 Oct 2007

Day care attendance early in life protects infants and young children from later developing asthma

The study, "Influence of early day care exposure on total IgE levels through age 3 years" can be found in the Articles in Press section of the JACI Web site, http://www.jacionline.org. The JACI is the peer-reviewed journal of the American Academy of Allergy, Asthma & Immunology (AAAAI).

19 Oct 2007

Accelr8 announces patent allowance for rapid bacterial diagnostic method

Accelr8 Technology Corporation has announced that it received notice of allowance on the first patent related to its BACcel rapid diagnostic platform.

19 Oct 2007

Biocontrol secures substantial funding from The Capital Fund

Scientists at Biocontrol, leading the world in developing new treatments to cure serious antibiotic-resistant infections, have secured a £250,000 investment from The Capital Fund.

19 Oct 2007

Honey for wound healing

Surgeons are being advised to consider the supermarket as well as the drugs cupboard when it comes to effective wound healing, according to a research review published in the October issue of IJCP, the International Journal of Clinical Practice.

18 Oct 2007

Baicalin shows promise for severe acute pancreatitis

¡°Qingyitang¡±, a representative prescription of Traditional Chinese Medicine for SAP was widely used in the orients countries.

18 Oct 2007

Accessory protein determines whether pheromones are detected

Pheromones are like the molecules you taste as you chomp on a greasy french fry: big and fatty.

17 Oct 2007

Technology to beat superbugs wins major funding

Scientists at Biocontrol, leading the world in developing new treatments to cure serious antibiotic-resistant infections, have secured a £250,000 investment from The Capital Fund.

17 Oct 2007

Ear infection superbug found to be resistant to all pediatric antibiotics

Researchers have discovered a strain of bacteria resistant to all approved drugs used to fight ear infections in children, according to an article to be published tomorrow in the Journal of the American Medical Association (JAMA).

17 Oct 2007

MRSA infection appears more widespread than previously thought

Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) appears to be more prevalent than previously believed, affecting certain populations disproportionately and is being found more often outside of health care settings, according to a study in the October 17 issue of JAMA, the Journal of the American Medical Association.

17 Oct 2007

Strain of the bacteria Streptococcus pneumoniae that causes ear infections emerges; resistant to antibiotics, pneumococcal vaccine

A strain of the bacteria Streptococcus pneumoniae, which can cause ear infections in children, has been detected that is resistant to all FDA-approved antibiotics for treatment of ear infections and is not covered by the pneumococcal 7-valent conjugate vaccine, according to a study in the October 17 issue of JAMA.

17 Oct 2007